14
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes

, , &
Pages 905-929 | Published online: 26 Sep 2008

References

  • Olsson R. A., Pearson J. D. Cardiovascular purinoreceptors. Physiol. Reviews 1990; 70: 761–845
  • Hamprecht B., Van Calker D. Nomenclature of adenosine receptors. Trends Pharmacol. Sci. 1985; 6: 153–154
  • Fredholm B. B., Dunwiddie T. V. How does adenosine inhibit transmitter release?. Trends Pharmacol. Sci. 1988; 9: 130–134
  • Sebastião A. M., Riberio J. A. Interactions between adenosine and phorbol esters or lithium at the frog neuromuscular junction. Br. J. Pharmacol. 1990; 100: 55–62
  • Nakahata N., Abe M. T., Matsuoka I., Ono T., Nakanishi H. Adenosine inhibits histamine-induced phosphoinositide hydrolysis mediated via pertussis toxin-sensitive G protein in human astrocytoma cells. J. Neurochem. 1991; 57: 963–969
  • Stiles G. L. Adenosine receptors. J. Biol. Chem. 1992; 267: 6451–6454
  • Bruns R. F., Lu G. H., Pugsley T. A. Characterization of the A2 adenosine receptor labelled by [3H]NECA in rat striatal membranes. Mol. Pharmacol. 1986; 29: 331–346
  • Wan W., Sutherland G. R., Geiger J. D. Binding of the adenosine A2-receptor ligand [3H]CGS 21680 to human and rat brain: Evidence for multiple affinity sites. J. Neurochem. 1990; 55: 1763–1771
  • Collis M. G., Hourani S. M.O. Adenosine receptor subtypes. Trends Pharmacol. Sci. 1993; 14: 360–366
  • Meyerhof W., Miiller-Brechlin R., Richter D. Molecular cloning of a novel putative G-protein coupled receptor expressed during rat spermiogenesis. FEBS lett. 1991; 284: 155–160
  • Zhou Q.-Y., Li C., Olah M. E., Johnson R. A., Stiles G. L., Civelli O. Molecular cloning and characterization of an adenosine receptor: The A3 adenosine receptor. Proc. Natl. Acad. Sci. USA 1992; 89: 7432–7436
  • Linden J., Taylor H. E., Robeva A. S., Tucker A. L., Stehele J. H., Rivkees S. A., Fink J. S., Reppert S. M. Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution. Mol. Pharmacol. 1993; 44: 524–532
  • Sajjadi F. G., Firestein G. S. cDNA cloning and sequence analysis of the human A3 adenosine receptor. Biochim. Biophys. Acta 1993; 1179: 105–107
  • Salvatore C. A., Jacobson M. A., Taylor H. E., Linden J., Johnson R. G. Molecular cloning and characterization of the human A3 adenosine receptor. Proc. Natl. Acad. Sci. USA 1993; 90: 10365–10369
  • Ramkumar V., Stiles G. L., Beaven M. A., Ali H. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 1993; 268: 16887–16890
  • Murphy K. M.M., Goodman R. R., Snyder S. H. Adenosine receptor localization in rat testis: Biochemical and autoradiographic evidence for association with spermatocytes. Endocrinology 1983; 113: 1299–1305
  • Stiles G. L., Pierson G., Sunay S., Parsons W. J. The rat testicular Al adenosine receptor-adenylate cyclase system. Endocrinology 1986; 119: 1845–1851
  • Monaco L., Conti M. Localization of adenosine receptors in rat testicular cells. Biol. Reprod. 1986; 35: 258–266
  • Cushing D. J., McConnaughey M. M., Mustafa S. J. Characterization of adenosine binding sites in bovine testicular tissue using 8-cyclopentyl-1,3-[3H]dipropylxanthine. Eur. J. Pharmacol. 1988; 152: 353–356
  • Nakata H. A1 adenosine receptor in rat testis membranes. J. Biol. Chem. 1990; 265: 671–677
  • Mazzoni M. R., Martini C., Lucacchini A. Regulation of agonist binding to A2a adenosine receptors: effects of guanine nucleotides (GDP[S] and GTP[S]) and Mg2+ ion. Biochim. Biophys. Acta 1993; 1220: 76–84
  • Martini C., Pennacchi E., Poli M. G., Lucacchini A. Solubilization of adenosine A1 binding sites from sheep cortex. Neurochem. Int. 1985; 7: 1017–1020
  • Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265–275
  • Salomon Y. Adenylate cyclase assay. Advance in Cyclic Nucleotide Research, G. Brooker, P. Greengard, G. A. Robinson. Raven Press, New York 1979; 35–54
  • McPherson G. A. Analysis of radioligand binding experiments. J. Pharmacol. Methods 1985; 14: 213–228
  • Cheng Y. C., Prusoff W. H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzyme reaction. Biochem. Pharmacol. 1973; 22: 3099–3108
  • Jacobson K. A., Nikodijevic O., Shi D., Gallo-Rodriguez C., Olah M. E., Stiles G. L., Daly J. W. A role for central A3-adenosine receptors. FEBS lett. 1993; 336: 50–57
  • Birnbaumer L. Transduction of receptor signal into modulation of effector activity by G proteins: the first 20 years or so. FASEB J. 1990; 4: 3178–3188
  • Van Galen P. J.M., Van Bergen A. H., Gallo-Rodriguez C., Melman N., Olah M. E., Ijzerman A. P., Stiles G. L., Jacobson K. A. A binding site model and structure-activity relationships for the rat A3 adenosine receptor. Mot. Pharmacol. 1994; 45: 1101–1111
  • Linden J. Cloned adenosine A3 receptors: pharmacological properties. species differences and receptor functions, Trends Pharmacol. Sci. 1994; 15: 298–306
  • Reddington M., Erfurth A, Less K. S. Heterogeneity of binding sites for N-ethylcarboxamido[3H]adenosine in rat brain: Effects of N-ethylmaleimide. Brain Res. 1986; 399: 232–239
  • Lohse M. J., Eiger B., Lindenborn-Fotinos J., Klotz K.-L., Schwabe U. Separation of solubilized A2 adenosine receptors of human platelets from non-receptor [3H]NECA binding sites by gel filtration. Naunyn-Schmiedebergs Arch. Pharmacol. 1988; 337: 64–68
  • Bruns R. F., Daly J. W., Snyder S. H. Adenosine receptors in brain membranes: Binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phcnylxanthine. Proc. Natl. Acad. Sci. USA 1980; 77: 5547–5551
  • Williams M. Adenosine and Adenosine Receptors, M. Williams. Humana Press Inc., Clifton, NJ 1990; 1–15
  • Shen M.-R., Linden J., Chiang P.-H., Chen S.-S., Wu S.-N. Adenosine stimulates human sperm mobility via A2 receptors. J. Pharm. Pharmacol. 1993; 45: 650–653

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.